Pfizer Reverses Drug Price Hikes After Call with Trump and HHS Secretary
Major U.S. drug manufacturer Pfizer agreed to roll back July 1 drug price hikes after an “extensive discussion” with President Donald Trump on Tuesday.

Major U.S. drug manufacturer Pfizer agreed to roll back July 1 drug price hikes after an “extensive discussion” with President Donald Trump on Tuesday.

During Friday’s Democratic Weekly Address, Senator Debbie Stabenow (D-MI) discussed prescription drug prices and argued Republicans should join Democrats in taking action to lower drug prices. Transcript as Follows: “Today, President Trump is scheduled to speak about the need to
“We will have tougher negotiation, more competition, and much lower prices at the pharmacy counter and it will start to take effect very soon,” Trump said.
